Ticker Details
Absci Corporation Common Stock
IPO Date:	July 22, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$451.41M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 4.34%
Avg Daily Range (30 D):	$0.09 | 3.36%
Avg Daily Range (90 D):	$0.11 | 3.52%

Institutional Daily Volume
Avg Daily Volume:	1.69M
Avg Daily Volume (30 D):	3.6M
Avg Daily Volume (90 D):	3.26M

Trade Size
Avg Trade Size (Sh.):	178
Avg Trade Size (Sh.) (30 D):	211
Avg Trade Size (Sh.) (90 D):	210

Institutional Trades
Total Institutional Trades:	319
Avg Institutional Trade:	$1.61M
Avg Institutional Trade (30 D):	$1.34M
Avg Institutional Trade (90 D):	$1.29M
Avg Institutional Trade Volume:	.39M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.66M
Avg Closing Trade (30 D):	$1.18M
Avg Closing Trade (90 D):	$1.26M
Avg Closing Volume:	411.94K

News

Mar 3, 2026 @ 1:00 PM Absci Strengthens Clinical Leadership with Appoint... Source: Na

Oct 29, 2025 @ 8:05 PM Absci to Report Business Updates and Third Quarter... Source: Globe Newswire

Oct 27, 2025 @ 12:00 PM Absci to Participate in Upcoming Investor Conferen... Source: Absci Corporation

Oct 14, 2025 @ 3:41 PM Absci Stock Offers High-Risk AI Biotech Exposure W... Source: Nathan Reiff

Oct 9, 2025 @ 3:00 PM Computer-Aided Drug Design (CADD) Market Competiti... Source: Towards Healthcare

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.84	$-.19	$-.84
Diluted EPS	$-.84	$-.19	$-.84
Revenue	$2.8M	$.65M	$2.8M
Gross Profit
Net Income / Loss	$-115.18M	$-29.56M	$-115.18M
Operating Income / Loss	$-120.32M	$-31.04M	$-120.32M
Cost of Revenue
Net Cash Flow	$-37.14M	$-5.79M	$-37.14M
PE Ratio